A synthetic substance that belongs to the sex hormone family but has no effect on sex characteristics and is not really a hormone* was reported last week to be the most promising new weapon in the drug treatment of breast cancer. Dr. Albert Segaloff, of New Orleans' Alton Ochsner Medical Foundation, described the paradoxical chemical and its promising performance to 750 experts gathered in Washington by the Public Health Service's Cancer Chemotherapy National Service Center to report progress on the most active sector of the anticancer front (TIME, July 27).
In most women,...
To continue reading:
or
Log-In
